GLP-1 Pipeline Update: November 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
SSRIs increase serotonin broadly, and the downstream effect on 5-HT2C receptors specifically suppresses sexual desire and delays or prevents orgasm
OK and JS wrote and revised the manuscript
glutathione provides the protection
Kanbay M, Copur S, Siriopol D, Yildiz AB, Gaipov A, van Raalte DH, et al
10.1167/iovs.65.1.23 197 YakinM.EksiogluU.SadicM.KocaG.Ozkan-UneyG.YumusakN.et al (2017)